Background: It has often been reported that thyroid-specific autoimmune diseases, such as Hashimoto's thyroiditis and Graves’ disease, could increase the risk of thyroid cancer, but the association between other autoimmune diseases beyond thyroid and thyroid cancer has not been well investigated. This study aimed to examine the risk of thyroid cancer in patients with 8 autoimmune diseases compared with those without autoimmune diseases. Methods: This nationwide retrospective matched cohort study was conducted to investigate the relationship of 8 autoimmune diseases (Hashimoto's thyroiditis, Graves’ disease, type 1 diabetes mellitus, Sjogren’s disease, inflammatory bowel disease, vitiligo, systemic lupus erythematosus, rheumatoid arthritis) with the risk of incident thyroid cancer using the National Health Insurance Service- National Sample Cohort. The Cox-proportional hazard model was used to estimate the adjusted hazard ratio (HR) and 95% confidence intervals (95% CI) for thyroid cancer in relation to each of autoimmune disease compared with control group without autoimmune disease. Results: During the average follow-up of 9.49 years, 138 thyroid cancer cases were newly developed in control group and 268 cases were occurred in group with 8 autoimmune diseases. For all of study participants, the risk of thyroid cancer was significantly increased in patients with Hashimoto’s thyroiditis (HR=2.10 [1.57 – 2.81]), Graves’ disease (HR=2.67 [1.99 – 3.62]), inflammatory bowel disease (HR=2.06 [1.50 – 2.83]), vitiligo (HR=1.71 [1.13 – 2.59]), rheumatoid arthritis (HR=1.76 [1.07 – 2.90]), and total of 8 autoimmune diseases (HR=1.97 [1.60 – 2.42]) compared with control group without autoimmune diseases. When autoimmune diseases were divided into three types, thyroid-specific autoimmune diseases (HR=2.37 [1.85 – 3.03]) showed the strongest and significant association with thyroid cancer, followed by local autoimmune diseases (HR=1.83 [1.41 – 2.38]), and systemic autoimmune diseases (HR=1.77 [1.14 – 2.74]). Conclusions: Specific autoimmune diseases – especially for thyroid specific autoimmune disease, vitiligo, inflammatory bowel disease and rheumatoid arthritis – were associated with increased risk for thyroid cancer.
1 January 2023 in Annals of Occupational and Environmental Medicine
Background: The number of patients with diabetes and impaired fasting blood glucose in Korea is rapidly increasing compared to the past, and other metabolic indicators of population are also changed in recent years. To clarify the mechanism more clearly, we investigated the association between fasting blood glucose and incidence of pancreatic cancer in this retrospective cohort study. Methods: In Korea National Health Information Database, 19,050 participants without pancreatic cancer in 2009 were enrolled, and followed up until 2013. We assessed the risk of incident pancreatic cancer according to the quartile groups of fasting blood glucose level (quartile 1: <88 mg/dL, quartile 2: 88–97 mg/dL, quartile 3: 97–109 mg/dL and quartile 4: ≥109 mg/dL). Multivariate Cox-proportional hazard model was used in calculating hazard ratios (HRs) and 95% confidence interval (CI) for incident pancreatic cancer. Results: Compared with quartile1 (reference), unadjusted HRs and 95% CI for incident pancreatic cancer significantly increased in order of quartile2 (1.39 [1.01–1.92]), quartile3 (1.50 [1.09–2.07]) and quartile4 (2.18 [1.62–2.95]), and fully adjusted HRs and 95% CI significantly increased from quartile2 (1.47 [1.05–2.04]), quartile3 (1.61 [1.05–2.04]) to quartile4 (2.31 [1.68–3.17]). Conclusion: Fasting blood glucose even with pre-diabetic range was significantly associated with the incident pancreatic cancer in Korean.
1 January 2023 in Annals of Occupational and Environmental Medicine
OBJECTIVES: Our study examined the dose-response relationship between smoking amounts (pack-years) and the risk of developing pancreatic cancer in Korean men.METHODS: Of 125,743 participants who underwent medical health checkups in 2009, 121,408 were included in the final analysis and observed for the development of pancreatic cancer. We evaluated the associations between smoking amounts and incident pancreatic cancer in 4 groups classified by pack-year amounts. Cox proportional hazards models were used to estimate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of incident pancreatic cancer by comparing groups 2 (40 pack-year smokers) with group 1 (never smokers).RESULTS: During 527,974.5 person-years of follow-up, 245 incident cases of pancreatic cancer developed between 2009 and 2013. The multivariate-adjusted HRs (95% CIs) for incident pancreatic cancer in groups 2, 3, and 4 were 1.05 (0.76 to 1.45), 1.28 (0.91 to 1.80), and 1.57 (1.00 to 2.46), respectively (p for trend=0.025). The HR (95% CI) of former smokers showed a dose-response relationship in the unadjusted model, but did not show a statistically significant association in the multivariate-adjusted model. The HR (95% CI) of current smokers showed a dose-response relationship in both the unadjusted (p for trend=0.020) and multivariate-adjusted models (p for trend=0.050).CONCLUSIONS: The risk of developing pancreatic cancer was higher in current smokers status than in former smokers among Korean men, indicating that smoking cessation may have a protective effect.